0000849146-22-000050.txt : 20220822 0000849146-22-000050.hdr.sgml : 20220822 20220822173636 ACCESSION NUMBER: 0000849146-22-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220818 FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neufeld Alissa CENTRAL INDEX KEY: 0001866289 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 221184609 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD, SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 4 1 wf-form4_166120417335419.xml FORM 4 X0306 4 2022-08-18 0 0000849146 Lifevantage Corp LFVN 0001866289 Neufeld Alissa 3300 TRIUMPH BLVD, SUITE 700 LEHI UT 84043 0 1 0 0 General Counsel Common Stock 2022-08-18 4 A 0 24039 0 A 60504 D Performance Restricted Stock Units 2022-08-18 5 A 0 E 24039 0 A Performance Restricted Stock Units 24039.0 24039 D This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 1/3 of the total number of units will vest on the first anniversary of the grant date and (ii) the remaining units will vest in equal installments as of the first day of each of the eight calendar quarters thereafter. Each PRSU represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 1/3 of the earned award will vest on the first anniversary of the grant date and (ii) the remainder of the earned award will vest in equal installments as of the first day of each of the eight calendar quarters thereafter. /s/ Alissa Neufeld 2022-08-22